Literature DB >> 16081986

Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains.

Judith G Alamares1, Jianrong Li, Ronald M Iorio.   

Abstract

Newcastle disease virus (NDV) strains are classified as having high (velogenic), intermediate (mesogenic), or low (lentogenic) pathogenesis and virulence in chickens. Recent studies have established that the hemagglutinin-neuraminidase (HN) protein plays an important role in viral tropism and virulence. A monoclonal antibody (AVS-I) has previously been shown to be specific for lentogenic strains of NDV (Srinivasappa et al., Avian Dis. 30:562-567, 1986) and is routinely used to identify these strains. We have used competition antibody binding assays with a previously characterized panel of monoclonal antibodies, binding to chimeric HN proteins, and the characterization of an escape mutant to localize the binding site of AVS-I to the extreme carboxy terminus of the protein. In addition, we have shown that AVS-I does recognize at least one mesogenic strain and one velogenic strain of the virus, calling into question the potential of this antibody as a diagnostic reagent for avirulent NDV strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081986      PMCID: PMC1233966          DOI: 10.1128/JCM.43.8.4229-4233.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.

Authors:  R M Iorio; J B Borgman; R L Glickman; M A Bratt
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.

Authors:  Y Nagai; H D Klenk; R Rott
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

4.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

5.  Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria.

Authors:  R M Iorio; K A Lawton; P M Nicholson; M A Bratt
Journal:  Virus Res       Date:  1984-10       Impact factor: 3.303

6.  Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.

Authors:  R M Iorio; M A Bratt
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

7.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity.

Authors:  R M Iorio; G M Field; J M Sauvron; A M Mirza; R Deng; P J Mahon; J P Langedijk
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

10.  The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.

Authors:  Zhuhui Huang; Aruna Panda; Subbiah Elankumaran; Dhanasekaran Govindarajan; Daniel D Rockemann; Siba K Samal
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  2 in total

1.  Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt.

Authors:  Ibrahim Moharam; Olayinka Asala; Sven Reiche; Hafez Hafez; Martin Beer; Timm Harder; Christian Grund
Journal:  Virol J       Date:  2021-04-26       Impact factor: 4.099

2.  Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus.

Authors:  Zhongyuan Jin; Qiaolin Wei; Youkun Bi; Yongshan Li; Na Huo; Sujing Mou; Wenbin Wang; Haijin Liu; Zengqi Yang; Hongjun Chen; Sa Xiao
Journal:  Virol J       Date:  2021-01-06       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.